Tolterodine Tartrate

酒石酸托特罗定

Report date: 2022/08/26 10:28:14
NME

Base Information

Drug NameTolterodine Tartrate
Drug Alias Nametolterodinum托特罗定酒石酸盐托特药定tolterodinaDetrusitol XL +[15] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor antagonists
TargetsMuscarinic acetylcholine receptor
Therapy Area/IndicationsUrinary IncontinenceNocturnal EnuresisUrinary Bladder, Overactive +[4] 
Global Approved IndicationsUrinary Bladder, Overactive
Approved Indications in ChinaUrinary Bladder, Overactive
Original Approved Country/TerritoryUnited States
Original Approved Date1998/03/25
Country/TerritoryUnited StatesSingaporeAustralia +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesUpjohn IncPfizer IncNanjing Meirui Pharma Co Ltd
Inactive CompaniesViatrisGlaxosmithkline PlcInje University +[5] 
Active IndicationsUrinary Bladder, Overactive
Inactive IndicationsUrinary IncontinenceNocturnal EnuresisUrinary Bladder Diseases

Other Information

ATC CodeG04BD07
Related LinksWikipediaDrugBankKEGG